The introduction of a novel monoclonal antibody to the US market in 2023 offers a groundbreaking option for alleviating pain associated with canine osteoarthritis. Test your knowledge of monoclonal antibody therapies with this quiz, and learn the ins and outs of this unique tool for managing OA.